India Pesticides Ltd Q2 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/3gicrvwvzwfaw50f3rpcc3c0.pdf

Key Takeaways


Export Recovery & Demand Drivers

D.K. Jain: "We have visited a lot of our customers in their factories and offices across the world, including Australia, Europe, U.S.A., etc. And that has given a more personal touch to the business, and that's how we have got increased orders from our various customers across the geographies."

Domestic & Seasonal Dynamics


Capacity Expansion & Backward Integration

D.K. Jain: "That is more of a strategic nature in the sense we want to reduce our dependence on the import of this material because we are already making the forward integrated molecules from this."

Shalvis Specialities Progress


Margins & Working Capital


Long-Term Roadmap to ₹3,000 Crores

D.K Jain: "Sir, we will try our best. That's what we have aimed at. We have done a lot of field work. We have done a lot of meetings and we are quite confident that by that time, we would be very near to that target."

Guidance & Commitments

CommitmentSpecificsTimeline
FY26 revenueApproximately ₹1,000 crores; may slightly surpassFY26 full year
FY26 EBITDA marginMaintain 18%-20% rangeH2 FY26
FY27 standalone growthAt least 20% over FY26FY27
FY27 EBITDA marginSustainable at 18%-20%FY27
Shalvis revenue contributionAround ₹100 croresFY27 (next year)
PEDA capacity utilizationFull utilization of 8,500 MTFY27 (next year)
Working capital reductionInventory down ≥20 days, receivables down 10-15 days; total 25-30 days further reductionBy March 2026
Pretilachlor and intermediate revenueMinimum ₹250 croresFY27
New molecule introductions in ShalvisAt least 2 molecules, revenue at 2x the capex investedFY27 (next year)
Long-term revenue target₹3,000 croresFY30 or FY31

Key Metrics

MetricQ2 FY26
Revenue₹295 crores, +26% YoY
H1 FY26 revenue₹579 crores, +26% YoY
FY26 revenue guidance~₹1,000 crores
EBITDA₹54 crores, +37.6% YoY
EBITDA margin18.3%, up from 16.6% in Q2 FY25
Net profit₹32 crores, +22% YoY
PAT margin10.7%
H1 FY26 EBITDA₹108 crores, +53% YoY
H1 FY26 EBITDA margin18.6%
H1 FY26 net profit₹67 crores, +48% YoY
Export revenue₹140 crores, nearly doubled from ₹74 crores in Q2 FY25
Domestic revenue₹150 crores, marginally lower YoY
Revenue mix (technical/API vs formulation)66% technical and API, 34% formulation
Technical utilizationover 73%
ROCE18.8%, up from 17.6% in Q2 FY25
Net cash and cash balance~₹80 crores
Working capital days174 days, reduced from 255 days as at 31 March 2025
Formulation capacity10,000 metric tons, expanded from 6,500 metric tons
Capex deployed (IPL and Shalvis)₹52 crores
Shalvis expected revenue next year~₹100 crores
Long-term revenue target₹3,000 crores by FY30-31